Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-22-002324

Chief Operating Officer acquired 1,838 shares (grant or award)

  • Chief Operating Officer gave up 681 shares (to pay taxes)
  • Chief Operating Officer acquired 1,964 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Tessari Eben · Chief Operating Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-15 Grant or award : show line 1 in the form +868 $11.49 $9,973 106,810 D
2022-01-15 Grant or award : show line 2 in the form +970 $9.63 $9,341 107,780 D
2022-03-16 Exercise or conversion : show line 3 in the form +1,964 109,744 D
2022-03-16 Shares withheld for taxes : show line 4 in the form −681 $10.13 $6,899 109,063 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-16 Exercise or conversion : show line 5 in the form Restricted Share Unit −1,964 5,892 D
Loading xslF345X03/edgar.xml…